导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 98.56% | 1/1050 |
| 近一周 | -0.24% | 45/1104 |
| 近一月 | -6.04% | 728/1102 |
| 近一季 | 3.74% | 136/1092 |
| 近半年 | 66.44% | 5/1070 |
| 近一年 | 99.11% | 9/1018 |
| 近两年 | 199.03% | 56/926 |
| 近三年 | 117.48% | 71/834 |
| 成立以来 | 61.93% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
17.73% 12/1070 |
123.57% 7/1101 |
- - |
- - |
| 2025 | 23.09% 617/1065 |
-0.20% 806/1014 |
-5.28% 963/1038 |
39.00% 208/1050 |
-6.33% 757/1065 |
| 2024 | -8.11% 749/1011 |
-7.80% 690/960 |
-4.94% 631/983 |
7.62% 793/991 |
-2.57% 494/1011 |
| 2023 | 4.08% 48/952 |
13.62% 62/880 |
11.79% 14/895 |
-14.39% 757/915 |
-4.29% 432/952 |
| 2022 | -37.44% 718/867 |
-20.54% 547/773 |
10.71% 240/806 |
-14.94% 561/845 |
-16.39% 835/867 |
| 2021 | 32.69% 58/740 |
-11.77% 521/580 |
26.03% 73/659 |
12.08% 43/704 |
6.47% 161/740 |
| 2020 | 22.56% 376/554 |
-2.55% 224/419 |
15.14% 348/466 |
-2.94% 445/517 |
12.54% 268/554 |
| 2019 | 24.83% 312/410 |
26.83% 559/1146 |
-7.53% 886/1228 |
0.91% 310/390 |
5.47% 333/410 |
| 2018 | - - |
- - |
- - |
-3.70% 402/1000 |
-5.91% 79/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 汇安趋势动力股票A VS. 东吴新产业精选股票A(580008) |